Clay Thorp
@claythorp5480
Director
Building PhaseBio Pharmaceuticals Inc as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Lysosomal Therapeutics, Inc. was founded in 2011 and has no closure on record.
Named alongside
At GeneCentric Therapeutics, Inc.
- Arnold LevineDirector
- Arnold Neil LevineDirector
- Arnold V. LevineDirector
- Charles Neil PerouDirector
- Charles PerouExecutive Officer, Director
- Clay Neil ThorpDirector
- Clay V. ThorpDirector
- David Neil HayesExecutive Officer, Director
At Lysosomal Therapeutics, Inc.
- Bernard DavitianDirector
- Bruce BoothDirector
- Bruce L BoothDirector
- Carole E. NuechterleinDirector
- Carole NeuchterleinDirector
- Carole NuechterleinDirector
- Clay E. ThorpDirector
- Cornelis BeenExecutive Officer, Director
At ORIG3N, Inc.
- Byron SmithDirector
- Clay Y. ThorpDirector
- Doug Y. JamisonDirector
- Dylan DaiDirector
- Elona BaumDirector
- George Y. HaraDirector
- Jonathan Y. MeltzerDirector
- Justin XiangDirector
At PhaseBio Pharmaceuticals Inc
- Ashutosh ChilkotiDirector
- Asish K. XavierDirector
- Bibhash MukhopadhyayDirector
- Caroline LoewyDirector
- Guy K. FishDirector
- James K. BarrettDirector
- Joel SussmanExecutive Officer
- John SharpExecutive Officer
- Bridget Ann MartellExecutive Officer, Director
Contribution
Clay's ideas, decisions and failures appear here once this profile is claimed.
Companies
- PhaseBio Pharmaceuticals IncPharmaceutical Preparations; formerly Phase Biosciences Inc; filing with the SEC since 2002Director · Biotechnology · Malvern, United States
- Lysosomal Therapeutics, Inc.Director · Biotechnology · CAMBRIDGE, United States · Founded 2011
- StrideBio, Inc.Director · Biotechnology · DURHAM, United States · Founded 2015
- ORIG3N, Inc.Director · Biotechnology · BOSTON, United States · Founded 2014
- Vigil Neuroscience, Inc.Biological Products, (No Diagnostic Substances); filing with the SEC since 2020Director · Biological Products, (No Diagnostic Substances) · CAMBRIDGE, United States · Founded 2020
- GeneCentric Therapeutics, Inc.formerly GeneCentric Diagnostics, Inc.; filing with the SEC since 2011Director · Biotechnology · DURHAM, United States
- PIPr Therapeutics, Inc.formerly Artizan Biosciences, Inc.; filing with the SEC since 2016Director · Biotechnology · DURHAM, United States